Benchmark for Functional Vision Loss Uncovered in Older Adults
-
By
-
Andrea Surnit
-
July 7, 2026
-
3 min
By
Andrea Surnit
July 7, 2026
Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.
July 20, 2026
Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.
March 11, 2026